Venous Thromboembolism Prophylaxis After Hospital Discharge: Transition to Preventive Care

References

• . Maynard G, Stein J; Society of Hospital Medicine; Agency for Healthcare Research and Quality. Preventing hospital-acquired venous thromboembolism: a guide for effective quality improvement. AHRQ publication no. 08-0075. http://www.ahrq.gov/qual/vtguide/vtguide.pdf. Published August 2008. Accessed January 24, 2011
   Google Scholar
• . US Department of Health and Human Services. The Surgeon General's call to action to prevent venous thrombosis and pulmonary embolism: 2008. http://www.surgeongeneral.gov/topics/deepvein/calltoaction/call-to-action-on-dvt-2008.pdf. Accessed January 24, 2011
   Google Scholar
• . Cohen AT, Tapson VF, Bergmann JF, ; ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371(9610):387–394
   PubMed Web of Science ®Google Scholar
• . Tapson VF, Decousus H, Pini M, ; IMPROVE Investigators. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest. 2007;132(3):936–945
   PubMed Web of Science ®Google Scholar
• . Kahn SR, Panju A, Geerts W, ; CURVE study investigators. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res. 2007;119(2):145–155
   PubMed Web of Science ®Google Scholar
• . QualityNet. Medicare Quality Improvement Community (MedQIC) Web site. SCIP project information. http://www.medqic.org/dcs/ContentServer?cid=1122904930422&pagename=Medqic%2FContent%2FParentShellTemplate&parentName=Topic&c=MQParents. Accessed January 24, 2011
   Google Scholar
• . The Joint Commission. The Joint Commission venous thromboembolism (VTE) core measure set. 2009. http://www.jointcommission.org/assets/1/6/Venous%20Thromboembolism.pdf. Accessed January 24, 2011
   Google Scholar
• . Society of Hospital Medicine. Society of Hospital Medicine VTE prevention collaborative. 2009. http://www.hospitalmedicine.org/AM/Template.cfm?Section=Home&TEMPLATE=/CM/HTMLDisplay.cfm&CONTENTID=11323. Accessed January 24, 2011
   Google Scholar
• . The Medicare Learning Network®. Hospital-acquired conditions (HAC) in acute inpatient prospective payment system (IPPS) hospitals. Factsheet. http://www.cms.gov/HospitalAcqCond/downloads/HACFactsheet.pdf. Published October 2010. Accessed January 24, 2011
   Google Scholar
• . Deitelzweig S, Thompson S, Lin J, McMorrow D, Johnson B. Impact of CMS VTE Hospital Acquired Conditions (HAC) Policy on Hospital Cost and Revenue Associated with Major Surgical Hip and Knee Procedures [ASH abstract 3824]. Blood. 2010;116(21):3824
   Web of Science ®Google Scholar
• . The Patient Protection and Affordable Care Act. 2010. http://democrats.senate.gov/reform/patient-protection-affordable-care-act-as-passed.pdf. Accessed January 24, 2011
   Google Scholar
• . Dove JT, Weaver WD, Lewin J. Health care delivery system reform: accountable care organizations. J Am Coll Cardiol. 2009;54(11):985–988
   PubMed Web of Science ®Google Scholar
• . Medicare Payment Advisory Commission. Report to the congress: reforming the delivery system. http://www.medpac.gov/documents/Jun08_EntireReport.pdf. Published June 2008. Accessed January 24, 2011
   Google Scholar
• . Kripalani S, LeFevre F, Phillips CO, Williams MV, Basaviah P, Baker DW. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA. 2007;297(8):831–841
   PubMed Web of Science ®Google Scholar
• . Snow V, Beck D, Budnitz T, ; American College of Physicians; Society of General Internal Medicine; Society of Hospital Medicine; American Geriatrics Society; American College of Emergency Physicians; Society of Academic Emergency Medicine. Transitions of Care Consensus Policy Statement American College of Physicians-Society of General Internal Medicine-Society of Hospital Medicine-American Geriatrics Society-American College of Emergency Physicians-Society of Academic Emergency Medicine. J Gen Intern Med. 2009;24(8):971–976
   PubMed Web of Science ®Google Scholar
• . DeFrances CJ, Hall MJ. 2005 National Hospital Discharge Survey. Adv Data. 2007;385:1–19
   PubMedGoogle Scholar
• . Amin A, Lin J, Ryan A. Lack of thromboprophylaxis across the care continuum in US medical patients. Hosp Pract (Minneap). 2010;38(3):17–25
   PubMedGoogle Scholar
• . Amin AN, Lin J, Ryan A. Need to improve thromboprophylaxis across the continuum of care for surgical patients. Adv Ther. 2010;27(2):81–93
   PubMed Web of Science ®Google Scholar
• . Spyropoulos AC, Hussein M, Lin J, Battleman D. Rates of venous thromboembolism occurrence in medical patients among the insured population. Thromb Haemost. 2009;102(5):951–957
   PubMed Web of Science ®Google Scholar
• . Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111(10):4902–4907
   PubMed Web of Science ®Google Scholar
• . Carmody BJ, Sugerman HJ, Kellum JM, . Pulmonary embolism complicating bariatric surgery: detailed analysis of a single institution's 24-year experience. J Am Coll Surg. 2006;203(6):831–837
   PubMed Web of Science ®Google Scholar
• . White RH, Romano PS, Zhou H, Rodrigo J, Bargar W. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med. 1998;158(14):1525–1531
   PubMedGoogle Scholar
• . Lotke PA, Steinberg ME, Ecker ML. Significance of deep venous thrombosis in the lower extremity after total joint arthroplasty. Clin Orthop Relat Res. 1994;299:25–30
   Google Scholar
• . Sweetland S, Green J, Liu B, ; Million Women Study collaborators. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ. 2009;339:b4583
   PubMed Web of Science ®Google Scholar
• . Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet. 2001;358(9275): 9–15
   PubMed Web of Science ®Google Scholar
• . Eriksson BI, Lassen MR; PENTasaccharide in HIp-FRActure Surgery Plus Investigators. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study. Arch Intern Med. 2003;163(11):1337–1342
   PubMedGoogle Scholar
• . Geerts WH, Bergqvist D, Pineo GF, ; American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133( 6 suppl):381S–453S
   PubMed Web of Science ®Google Scholar
• . Cardiovascular Disease Educational and Research Trust; Cyprus Cardiovascular Disease Educational and Research Trust; European Venous Forum; International Surgical Thrombosis Forum; International Union of Angiology; Union Internationale de Phlébologie. Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int Angiol. 2006;25(2):101–161
   PubMed Web of Science ®Google Scholar
• . White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost. 2003;90(3):446–455
   PubMed Web of Science ®Google Scholar
• . Kakkar AK, Haas S, Wolf H, Encke A. Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients: the MC-4 cancer substudy. Thromb Haemost. 2005;94(4):867–871
   PubMed Web of Science ®Google Scholar
• . Bergqvist D, Agnelli G, Cohen AT, ; ENOXACAN II Investigators. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346(13):975–980
   PubMed Web of Science ®Google Scholar
• . Rasmussen MS, Jorgensen LN, Wille-Jørgensen P, ; FAME Investigators. Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study. J Thromb Haemost. 2006;4(11):2384–2390
   PubMed Web of Science ®Google Scholar
• . Khorana AA, Streiff MB, Farge D, . Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action. J Clin Oncol. 2009;27(29):4919–4926
   PubMed Web of Science ®Google Scholar
• . Stahl TJ, Gregorcyk SG, Hyman NH, Buie WD; Standards Practice Task Force of The American Society of Colon and Rectal Surgeons. Practice parameters for the prevention of venous thrombosis. Dis Colon Rectum. 2006;49(10):1477–1483
   PubMed Web of Science ®Google Scholar
• . Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293(6):715–722
   PubMed Web of Science ®Google Scholar
• . Mandalà M, Falanga A, Piccioli A, ; working group AIOM. Venous thromboembolism and cancer: guidelines of the Italian Association of Medical Oncology (AIOM). Crit Rev Oncol Hematol. 2006;59(3):194–204
   PubMed Web of Science ®Google Scholar
• . Lyman GH, Khorana AA, Falanga A, ; American Society of Clinical Oncology. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol. 2007;25(34):5490–5505
   PubMed Web of Science ®Google Scholar
• . National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN Guidelines™). 2010. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed January 24, 2011
   Google Scholar
• . Mandalà M, Falanga A, Roila F; ESMO Guidelines Working Group. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management. Ann Oncol. 2010;21( suppl 5):v274–v276
   PubMed Web of Science ®Google Scholar
• . Hussein MA. Thromboembolism risk reduction in multiple myeloma patients treated with immunomodulatory drug combinations. Thromb Haemost. 2006;95(6):924–930
   PubMed Web of Science ®Google Scholar
• . Zangari M, Anaissie E, Barlogie B, . Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy. Blood. 2001;98(5):1614–1615
   PubMed Web of Science ®Google Scholar
• . Zangari M, Siegel E, Barlogie B, . Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy. Blood. 2002;100(4):1168–1171
   PubMed Web of Science ®Google Scholar
• . Bennett CL, Angelotta C, Yarnold PR, . Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer. JAMA. 2006;296(21):2558–2560
   PubMed Web of Science ®Google Scholar
• . Uaprasert N, Voorhees PM, Mackman N, Key NS. Venous thromboembolism in multiple myeloma: current perspectives in pathogenesis. Eur J Cancer. 2010;46(10):1790–1799
   PubMed Web of Science ®Google Scholar
• . Francis CW. Clinical practice. Prophylaxis for thromboembolism in hospitalized medical patients. N Engl J Med. 2007;356(14):1438–1444
   PubMed Web of Science ®Google Scholar
• . Cohen AT, Davidson BL, Gallus AS, ; ARTEMIS Investigators. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ. 2006;332(7537):325–329
   PubMed Web of Science ®Google Scholar
• . Samama MM, Cohen AT, Darmon JY, . A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med. 1999;341(11):793–800
   PubMed Web of Science ®Google Scholar
• . Hull RD, Schellong SM, Tapson VF, ; EXCLAIM (Extended Prophylaxis for Venous ThromboEmbolism in Acutely Ill Medical Patients With Prolonged Immobilization) study. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial. Ann Intern Med. 2010;153(1):8–18
   PubMed Web of Science ®Google Scholar
• . Gallus A. ACP Journal Club. Extended-duration enoxaparin reduced VTE but increased major bleeding in patients with acute medical illness. Ann Intern Med. 2010;153(10):JC5–JC8
   PubMed Web of Science ®Google Scholar
• . ClinicalTrials.gov. NCT00571649. Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients (MAGELLAN). http://clinicaltrials.gov/ct2/show/NCT00571649. Accessed January 24, 2011
   Google Scholar
• . ClinicalTrials.gov. NCT00457002. Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness (ADOPT). http://clinicaltrials.gov/ct2/show/NCT00457002. Accessed January 24, 2011
   Google Scholar
• . Cohen AT, Spiro TE, Büller HR, . Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol. J Thromb Thrombolysis. 2011;31(4):407–416
   PubMed Web of Science ®Google Scholar
• . Kripalani S, Jackson AT, Schnipper JL, Coleman EA. Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists. J Hosp Med. 2007;2(5):314–323
   PubMed Web of Science ®Google Scholar
• . Spencer FA, Lessard D, Emery C, Reed G, Goldberg RJ. Venous thromboembolism in the outpatient setting. Arch Intern Med. 2007;167(14):1471–1475
   PubMed Web of Science ®Google Scholar
• . Warwick D, Friedman RJ, Agnelli G, . Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry. J Bone Joint Surg Br. 2007;89(6):799–807
   PubMedGoogle Scholar
• . ClinicalTrials.gov. NCT00853463. Discharge ALERT: Quality Improvement Initiative. http://clinicaltrials.gov/ct2/show/study/NCT00853463. Accessed January 24, 2011
   Google Scholar
• . Colwell CW Jr, Pulido P, Hardwick ME, Morris BA. Patient compliance with outpatient prophylaxis: an observational study. Orthopedics. 2005;28(2):143–147
   PubMed Web of Science ®Google Scholar
• . Wilke T, Moock J, Müller S, Pfannkuche M, Kurth A. Nonadherence in outpatient thrombosis prophylaxis with low molecular weight heparins after major orthopaedic surgery. Clin Orthop Relat Res. 2010;468(9):2437–2453
   PubMed Web of Science ®Google Scholar